To the full analysis
Henry Schein stock: growth
HSICHenry Schein reported $13.18B in revenue for fiscal 2025, up 4% on the prior year, up 5.4% a year on average over up to five years.
Daily figure as of 13 Nov 2026
Revenue (Annual rate)
5.1%
per year from 2006 to 2025, per share 7.2%
Earnings (Annual rate)
4.2%
per year from 2006 to 2025, per share 6.2%
Free cash flow (Annual rate)
6.7%
per year from 2006 to 2025, per share 8.8%
Growth per year by period
What reaches shareholders is growth per share: buybacks lift it, new shares dilute it.
| since 2020 | since 2015 | since 2006 | |
|---|---|---|---|
| Revenue | 5.4% | 2.2% | 5.1% |
| Revenue per share | 9.0% | 5.5% | 7.2% |
| Earnings | −0.2% | −1.8% | 4.2% |
| Earnings per share | 3.1% | 1.3% | 6.2% |
| Free cash flow | 0.8% | 1.1% | 6.7% |
| Free cash flow per share | 4.2% | 4.3% | 8.8% |
Fiscal years at a glance
How revenue and earnings grow
- Revenue
- Earnings
- Free cash flow
Figures as a table
| Year | Revenue | Earnings | Free cash flow |
|---|---|---|---|
| 2006 | $5.15B | $182.74M | $168.32M |
| 2007 | $5.92B | $234.97M | $213.39M |
| 2008 | $6.39B | $247.36M | $333.78M |
| 2009 | $6.54B | $308.64M | $345.26M |
| 2010 | $7.53B | $325.79M | $349.87M |
| 2011 | $8.53B | $367.66M | $509.45M |
| 2012 | $8.94B | $388.08M | $356.86M |
| 2013 | $9.56B | $444.09M | $603.96M |
| 2014 | $10.37B | $466.08M | $510.39M |
| 2015 | $10.63B | $479.06M | $515.16M |
| 2016 | $11.57B | $506.78M | $545.28M |
| 2017 | $12.46B | $406.3M | $464.01M |
| 2018 | $13.2B | $535.88M | $594.07M |
| 2019 | $9.99B | $507.97M | $577.87M |
| 2020 | $10.12B | $402.22M | $550M |
| 2021 | $12.4B | $623.91M | $630.57M |
| 2022 | $12.65B | $538M | $506M |
| 2023 | $12.34B | $416M | $313M |
| 2024 | $12.67B | $390M | $661M |
| 2025 | $13.18B | $398M | $573M |
Revenue by segment
How Henry Schein, Inc. makes its money and how that has shifted. Names are as the company reports them.
- Healthcare Distribution$12.7B96%
- Technology$509.2M4%
The company split earlier years differently. A history would not be comparable, so only 2018 is shown.
Figures as a table
| 2018 | Share 2018 | |
|---|---|---|
| Healthcare Distribution | $12.69B | 96.1% |
| Technology | $509.25M | 3.9% |
| Total revenue | $13.2B | 100% |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 27 Dec 2025
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral, published since 7 Nov 2026 (in the score history since 31 Mar 2022)
- Valuation signal Fairly valued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.